相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Interobserver variability for retreatment indications after Ranibizumab loading doses in neovascular age-related macular degeneration
Carsten Framme et al.
ACTA OPHTHALMOLOGICA (2012)
Delay to Treatment and Visual Outcomes in Patients Treated With Anti-Vascular Endothelial Growth Factor for Age-Related Macular Degeneration
Jonathan H. Lim et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2012)
Incidence of rhegmatogenous retinal detachments after intravitreal antivascular endothelial factor injections
Carsten H. Meyer et al.
ACTA OPHTHALMOLOGICA (2011)
Effectiveness of ranibizumab for neovascular age-related macular degeneration using clinician-determined retreatment strategy
A. Kumar et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2011)
Safety and Efficacy of a Flexible Dosing Regimen of Ranibizumab in Neovascular Age-Related Macular Degeneration: The SUSTAIN Study
Frank G. Holz et al.
OPHTHALMOLOGY (2011)
Risks of Mortality, Myocardial Infarction, Bleeding, and Stroke Associated With Therapies for Age-Related Macular Degeneration
Lesley H. Curtis et al.
ARCHIVES OF OPHTHALMOLOGY (2010)
Effectiveness of intravitreal ranibizumab for the treatment of neovascular age-related macular degeneration in a Canadian retina practice: a retrospective review
Taha Bandukwala et al.
CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE (2010)
Time between Symptom Onset and Assessment in Age-Related Macular Degeneration with Subfoveal Choroidal Neovascularization
Rainer Schalnus et al.
OPHTHALMOLOGICA (2010)
The Psychometric Validity of the NEI VFQ-25 for Use in a Low-Vision Population
Manjula Marella et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2010)
Reliability and Validity of the National Eye Institute Visual Function Questionnaire-25 in Patients with Age-Related Macular Degeneration
Dennis A. Revicki et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2010)
The As-Needed Treatment Strategy for Choroidal Neovascularization: A Feedback-Based Treatment System
Richard F. Spaide
AMERICAN JOURNAL OF OPHTHALMOLOGY (2009)
A Phase IIIb Study to Evaluate the Safety of Ranibizumab in Subjects with Neovascular Age-related Macular Degeneration
David S. Boyer et al.
OPHTHALMOLOGY (2009)
Randomized, double-masked, sham-controlled trial of ranibizumab for neovascular age-related macular degeneration: PIER study year 1
Carl D. Regillo et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2008)
Monitoring of AMD patients on anti-vascular endothelial growth factor (VEGF) treatment. Practial notes on functional and anatomical examination parameters from Drug approval studies, specialist information and case series
C. H. Meyer et al.
OPHTHALMOLOGE (2008)
An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (lucentis) for neovascular age-related macular degeneration
Anne E. Fung et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2007)
Subgroup analysis of the MARINA study of ranibizumab in neovascular age-related macular degeneration
David S. Boyer et al.
OPHTHALMOLOGY (2007)
Ranibizumab for neovascular age-related macular degeneration
Philip J. Rosenfeld et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
分享论文
